Leucine-rich repeat kinase 2 promotes the development of experimental severe acute pancreatitis

Yasuo Otsuka1, Akane Hara1, Kosuke Minaga1

  • 1Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.

PubMed

Insights

Leucine-rich repeat kinase 2 (LRRK2) plays a key role in severe acute pancreatitis (SAP) development. Fungal exposure activates LRRK2, leading to increased inflammation and SAP progression.

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • Gut bacteria translocation is a known driver of severe acute pancreatitis (SAP).
  • Emerging evidence links fungal infections to SAP, but the underlying mechanisms are unclear.
  • Leucine-rich repeat kinase 2 (LRRK2) regulates innate immunity against fungi.

Purpose of the Study:

  • To investigate the role of LRRK2 in the development of SAP.
  • To elucidate the mechanism by which gut fungi contribute to SAP via LRRK2 signaling.

Main Methods:

  • Utilized Lrrk2 transgenic (Tg) mice and control mice.
  • Administered LRRK2 inhibitors and anti-fungal drugs.
  • Assessed SAP severity, cytokine production (IL-6, TNF-α), and the Dectin-1 pathway.

Main Results:

  • LRRK2 inhibition attenuated SAP development.
  • Lrrk2 Tg mice exhibited exacerbated SAP with increased pro-inflammatory cytokines.
  • Anti-fungal treatment, but not broad-spectrum antibiotics, inhibited SAP in Lrrk2 Tg mice.
  • Inhibition of the Dectin-1 pathway protected Lrrk2 Tg mice from SAP.

Conclusions:

  • LRRK2 activation is implicated in SAP development.
  • Fungal exposure, mediated by LRRK2 and the Dectin-1 pathway, drives SAP through pro-inflammatory cytokine production.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
95
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
380
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
131
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
96
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K